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Pegbovigrastim injection (IMR) represents a new approach in overcoming mastitis. The 
objective of this study was to evaluate production parameters, overall health, time to first 
detected heat, and behavior of cows treated with IMR or a saline control. Study cows (n = 270) 
were blocked by parity group (multiparous or primiparous) and randomly assigned to control 
(CON, n = 144) or treatment (IMR, n = 126). Milk yield, fat, protein, lactose, solids nonfat 
percent, somatic cell count, and body condition, hygiene, and lameness were evaluated weekly. 
Animals were evaluated for metritis twice weekly via evaluation of rectal temperature, per 
rectum palpation, and uterine discharge until 30 days in milk. Farm staff recorded occurrence of 
other diseases. Neck tag and a leg tag, each with activity monitoring sensors, measured behavior 
and time to first detected estrus. The occurrence of clinical mastitis did not differ between 
treatments. Treated cows were 2.46 times more likely to develop metritis compared to control 
cows. Cows given IMR had increased odds of developing metritis, without altering mastitis 
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The transition period in dairy cows 
According to Drackley (1999), the biology of the dairy cow during the transition period 
represents "the new frontier" faced by the dairy industry. The same author explains that the 
transition period is poorly understood when compared to the knowledge of dairy cows during 
and after peak lactation. Hypocalcemia, ketosis, fatty liver, and displaced abomasum are 
metabolic diseases faced by cows mainly during this period and negatively impact the 
profitability of dairy operations (Mulligan and Doherty, 2008). Immunosuppression during the 
pre-partum period can increase susceptibility of dairy cows having mastitis, retained placenta, 
and metritis during early lactation (Kehrli and Roth, 1989; Kehrli et al., 1989). Metabolic and 
infectious diseases are linked etiologically, and unfortunately, this interrelationship regularly 
results in “cascade effects,” in which the occurrence of a certain disease increases the odds of 
other diseases to occur (Goff and Horst, 1996). Additionally, reduced fertility, reduced milk 
production, and increased incidence of lameness are consequences of this cascade effect 
(Mulligan and Doherty, 2008).  
Over the past several decades, dairy cattle have been selected for increased milk 
production. Such great milk production is possible because of the nutrients of the diet and 
mobilization of body tissue reserves, and without the ability to mobilize body reserves and the 
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nutrients from the diet, dairy cows would not be able to meet their genetic potential (Kelton et 
al., 1998).  
The physiological shift from a state of pregnant and non-lactating to non-pregnant and 
lactating is possible due to a phenomenon that Bauman and Currie (1980) termed homeorhesis. 
These authors defined homeorhesis as “coordinated and orchestrated changes in body tissues 
metabolism required to support a particular physiological status.” The transition from late 
gestation to early lactation is a classic example of homeorhesis.  
Nutrient demand from the mammary gland of high-producing dairy cows exceeds that of 
the rest of the body. The nutrient needs of the mammary tissue are of such magnitude that Brow 
(1969) suggested that the cow should be considered an appendage on the udder, rather than the 
reverse. At the onset of lactation, important modifications in the partitioning of nutrients and 
metabolism of the whole cow must occur to meet demands of the mammary gland (Convey, 
1974). Physiological adaptations involve most of the body tissues and relate to the metabolism of 
all nutrient classes: protein, lipids, carbohydrates, vitamins, and minerals (Bauman, 2000). 
The metabolic adaptations occurring with the onset of lactation are related to hormonal 
changes occurring throughout this period. Some of the hormone changes include: 1) decreased 
insulin; 2) increased somatotropin; 3) increased prolactin; 4) increased glucocorticoids; 5) 
decreased thyroid hormones; and 6) decreased insulin-like growth factor 1 (Petterson et al., 
1993). These hormonal changes lead to greater uptake of nutrients by the mammary gland. 
Interestingly, virtually all of the glucose produced in the liver is directed to the mammary gland 
(Bell, 1995). During lactation, less glucose is made available to other cells like the immune 
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system. The most common metabolic changes that dairy cows face during the transition from 
gestation to lactation is summarized in Table 1. 
The inability to adjust the metabolism quickly enough to meet the demands of the fetus 
and the mammary gland frequently results in acute and subclinical metabolic disorders (Bauman 
and Currie, 1985). Twenty years after Drackley (1999) described the transition period as “the 
new frontier” in dairy science, much still remains to be discovered. However, it is still of great 
importance considering 30 to 50% of cows in North America suffer from a metabolic or 
infectious disease in the weeks following calving (LeBlanc, 2010).  
Negative energy balance and metabolic diseases in dairy cattle 
Energy balance is the relationship between the energy in (calories taken into the body 
through feed) and energy out (calories being used in the body for maintenance, growth, and 
lactation). This relationship, defined by the laws of thermodynamics, dictates whether weight is 
lost, gained, or remains the same (Bauman, 1984). Most cows in their transition period are in 
negative energy balance (NEB) (Ospina et al., 2010), meaning the amount of energy consumed 
in the diet does not make up for energy expenditure. Severe NEB can result in increased 
incidence of infectious and metabolic diseases during the transition period (LeBlanc, 2010). 
Infectious diseases like metritis (Huzzey et al., 2007) and mastitis (Kehrli, 1991; Pyorala, 2008) 
and metabolic diseases like hypocalcemia (Reinhardt et al., 2011) and hyperketonemia (Sheehy 
et al., 2016) are highly prevalent during the transition period and can lead to productive and 
economic losses (McArt et al., 2015; Liang et al., 2017). 
During the last three weeks of gestation, the nutrient requirements for fetal development 
reach their peak (Bell, 1995). Additionally, synthesis of colostrum and milk further increases the 
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energy requirement by almost two times (NRC, 2001). For instance, the Nutrient Requirement 
Council estimates that the net energy of lactation requirement for a 570 kg primiparous cow two 
days before calving is 58.5 megajoule (MJ)/d. The energy required for the same animal to 
produce 20 kg of 4% fat milk two days after calving is 105.0 MJ/d (NRC, 2001). Despite the 
increase in requirements, cows typically decrease their average dry matter intake by 10 to 30% 
after calving (Drackley et al., 2005; Huzzey et al., 2007), further intensifying NEB.  The 
decreased dry matter intake in the last weeks of gestation is partially explained by the fetus size, 
which takes abdominal space, and consequently, decreases the amount of feed the rumen can 
hold (Block, 2010). Nevertheless, the decreased dry matter intake is mainly attributed to the 
hormonal alterations and physiological changes that happen in the periparturient period (Bertics 
et al., 1992; Grant, 1995). 
The NEB stimulates cows to mobilize body fat in the form of non-esterified fatty acids 
(NEFA), causing a subsequent accumulation of beta-hydroxybutyric acid (BHBA) in the blood. 
Both NEFA and BHBA are important energy metabolites that are traditionally used as indicators 
of NEB during the transition period (Duffield et al., 2009). During the transition from pregnancy 
to lactation a natural increase of NEFA and BHBA concentrations occur in the blood, 
particularly in high-yielding dairy cows (Bell, 1995). However, an excessive increase of these 
metabolites is often associated with metabolic syndromes, like fatty liver, ketosis, and displaced 
abomasum (Mulligan and Doherty, 2007), as well as decreased milk production (Kelton et al., 
1998), and poor reproductive performance (LeBlanc, 2010).  
Ketosis, or hyperketonemia, is a disease related to fat metabolism and typically occurs in 
dairy cows in early lactation (McArt, 2012). Intense NEB leads to adipose mobilization, which 
leads to an increase in NEFA concentration in the blood (Bauman, 1984). Serum NEFA is 
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directed to the synthesis of ketone bodies in the liver, like BHBA, acetoacetate, and acetone 
(Bauman, 1984).  
Clinical ketosis manifests as a decrease in appetite, weight loss, and a decrease in milk 
production (McArt, 2012), and its incidence in the United States has been reported to be between 
2 and 3% (McLaren et al., 2006; Seifi et al., 2011). Nevertheless, cows are more likely to suffer 
from subclinical ketosis, which is defined as an excess of circulating ketone bodies in the blood 
without clinical signs (Andersson, 1988). Incidence of subclinical ketosis has been estimated to 
average 43% (McArt et al., 2012), ranging from 26 to 56% with peak incidence of subclinical 
ketosis occuring at 5 DIM (McArt et al., 2011). 
Measuring BHBA is considered the gold standard for ketosis detection because this 
ketone body is more stable in blood than acetone or acetoacetate (Tyopponen and Kauppinen, 
1980). The most common cut point used to define subclinical ketosis is serum BHBA 
concentrations greater than 1,000 μmol/L (Duffield et al., 2009).  Nevertheless, Duffield et al. 
(2009) explained that in order to predict health risk in early lactation dairy cows, hyperketonemia 
should be defined at a BHBA serum concentration greater than 1,200 μmol/L, instead of 1,000 
μmol/L. 
Cows in early lactation with blood BHBA concentrations above 1,200 μmol/L have 
increased risk of developing displaced abomasum (DA) and metritis (Duffield et al., 2009; 
Ospina et al., 2010). In the first 30 DIM, 0.3% of cows without subclinical ketosis developed 
DA, while 6.5% of cows with subclinical ketosis developed DA (McArt et al., 2012).  
Furthermore, cows that tested positive for subclinical ketosis were 19.3 times more likely to 
develop a DA than cows without ketosis (McArt et al., 2012).   
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Excessive mobilization of fatty acids from adipose tissue, due to intense NEB, can result 
in accumulation of triacylglycerol (TAG) in hepatocytes and cause impairment of liver function 
(Mulligan and Doherty, 2007). Fatty liver, or hepatic lipidosis, is recognized as a major 
metabolic disease of dairy cows (Drackley, 1999). In dairy cows, fatty liver typically occurs in 
the first 4 weeks after calving (Grummer, 1993).  It is estimated that 50% of all cows have some 
accumulation of TAG in the liver (Jorritsma et al., 2000; Jorritsma et al., 2001). 
Bobe et al., (2004) defined fatty liver as “the percentage of TAG that causes detrimental 
effects to the health, productivity, and reproductive success of a cow.” The same authors 
explained that fatty liver could be classified based on the percentage of TAG in the liver and 
categorized as normal liver (less 1%), mild fatty liver (1 to 5%), moderate fatty liver (5 to 10%), 
and severe fatty liver (more than 10%) (Bobe et al., 2004). Accumulation of triglycerides greater 
than 1% of liver is significant for dairy cows as approximately 85% of glucose for metabolism is 
derived from the liver (Mulligan and Doherty, 2007). 
The average cost of fatty liver was estimated to be $145/case (Guard, 1994). Annually, 
the disease is estimated to cost over 60 million dollars to the dairy industry (Guard, 1994).  Fatty 
liver is associated with other metabolic diseases, in particular DA and ketosis (Bobe et al., 2004). 
With all of these metabolic disorders, cows either are or will be in a severe NEB (Bobe et al., 
2004). Fatty liver has also been associated with infectious diseases, as it increased duration of 
mastitis by three days (Hill et al., 1985) and increased severity of metritis (Haraszti et al., 1982). 
Displaced abomasum is a disorder in cattle in which the abomasum, or the “true 
stomach,” becomes distended with fluid or gas and shifts to an abnormal position (Weir and 
McNish, 1960). In healthy cattle, the abomasum lays on the abdominal floor (Dirsken, 1962). 
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Because of the natural anatomy of cattle, it is more common for the abomasum to displace to the 
left, known as a left-displaced abomasum, rather than to the right (Weir and McNish, 1960). 
When the abomasum moves from its normal position, it prevents the natural passage of gas and 
feed through the digestive system, creating a restriction that, if not treated, can lead to death 
(Dirsken, 1962). The treatment of these conditions usually involves abdominal surgery to correct 
the displacement (Weir and McNish, 1960). 
The incidence of DA is typically reported in the range of 3.5% to 5.0% (Goff, 2006; Van 
Winden, 2002). The economic cost of DA is usually the result of reduced milk yield, direct costs 
of treatment, and replacement costs due to premature culling (Sharver, 1997). In a stochastic 
model, Liang et al. (2017) estimated that the average left displaced abomasum costs per case 
were $432.48 ± 101.94 for primiparous cows, and $639.51 ± 114.10 for multiparous cows. The 
authors also explained that the greatest portion of the cost comes from veterinary treatment 
($197.22 ± 70.28 per case). Interestingly, Seifi et al., 2011 found that concentration of calcium 
bellow 2.2 mmol/L in the first 2 weeks post-partum were at greater risk for developing DA 
Furthermore, cows with serum BHBA greater than 1,000 mol/L displayed 13.6 times greater 
odds of developing DA than cows with values below 1,000 mol/L.  
Recent researchers have tested different feed strategies to reduce incidence of metabolic 
disease in cattle. Selenium and vitamin E supplementation (Robert et al., 1989), monensin 
(Duffield et al., 2003), or propylene glycol (Vaughn et al., 1993) may help in decreasing 
incidence of metabolic diseases, but results are not consistent. Hence, increasing dry matter 
intake and thus reducing NEB severity is still the best known strategy to reduce incidence of 
metabolic diseases like ketosis, fatty liver, and DA (Drackley, 1999). 
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Periparturient immune suppression in dairy cows 
Two weeks before calving, the cow’s defense mechanisms begin to weaken, reaching 
maximum suppression at parturition (Kehrli and Roth, 1989). The immune system remains 
suppressed until three weeks after calving (Kehrli and Roth, 1989). These changes are associated 
with alterations in hormone profiles, stress of parturition, and NEB (Mallard et al., 1997). 
Consequently, immune cells are impaired during the transition period (Kehrli et al., 1989; Kehrli 
and Roth, 1989).  
During the transition period, several functions of polymorphonuclear cells (PMN), 
especially neutrophils, are debilitated. The number of immature neutrophils in circulation 
increases, whereas the number of mature neutrophils in the blood decreases (Paape et al., 2002; 
Schukken et al., 2011). The synthesis of reactive oxygen species is reduced from one week 
before calving over the first two weeks after calving (Hoeben et al., 2000; Mehrzad et al. 2002), 
and the proportion of PMN expressing the adhesion receptor L-selectin, necessary for 
penetration of the cells at the site of infection, is diminished (Diez-Fraile et al., 2004). The 
suppression of several functions of bovine’s PMN can be the cause of postpartum diseases like 
mastitis, retained placenta, and metritis (Kehrli et al., 1989). 
Some investigators have hypothesized that the increase in circulating glucocorticoids at 
parturition is the main cause of immunosuppression (Burton et al., 2005; Weber et al., 2006). 
However, glucocorticoids are elevated for approximately 24 hours around the time of calving 
(Graugnard et al., 2012; Moyes et al., 2014). Thus, glucocorticoids alone cannot be the only 
factor causing immunosuppression in transition dairy cows. As mentioned previously, major 
changes in blood metabolites in transition dairy cows include increased concentration of NEFA 
and BHBA, as well as prioritization of glucose to the mammary gland rather than peripheral 
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tissues (Bell, 1995). Immune cells have a preference for glucose as an energy source 
(Newsholme et al., 1986; Newsholme et al., 1987). Glucose may have certain stimulatory effects 
in immune cells, including increased proliferation and differentiation of leukocytes, like T- and 
B-lymphocytes, and improved neutrophil chemotaxis and phagocytosis (Barghouthi et al., 1995; 
Pithon-Curi et al., 2004). In humans, Wolowczuk et al. (2008) stated that glucose should be 
considered quantitatively the most important fuel to fulfill the energy requirement of immune 
cells. The same authors explained how an effective immune response requires an increase in 
cellular proliferative, biosynthetic, and secretory activities, all processes that require great energy 
consumption. Interestingly, it was recently reported that increased extracellular concentrations of 
glucose can protect neutrophils from apoptotic death and that this protective effect is correlated 
with the rate of glucose utilization by the cells (Healy et al., 2002).  
Beta-hydroxybutyrate is negatively associated with the immune response because, 
besides not being the favorite source of energy to immune cells (Newsholme et al., 1987), 
elevated concentrations of BHBA can reduce neutrophils functions. For instance, it reduces extra 
cellular trap formation, chemotaxis, and phagocytosis (Grinberg et al., 2008; Ingvartsen and 
Moyes, 2015). Due to increased requirements by the mammary gland, glucose availability for the 
immune system is less during the early postpartum period, whereas blood concentration of 
BHBA and NEFA are increased. This may partly explain the naturally-occurring 





The term mastitis refers to the inflammation of the mammary gland. This term is derived 
from the Greek words mastos (meaning breast) and itis (meaning inflammation of). Physical 
trauma and chemical irritants can cause mastitis (NMC, 2002). However, most mastitis cases 
occur when microbes (bacteria and fungus) enter the teat opening and successfully establish an 
infection in the alveoli of the mammary gland (Harmon, 1994). The inflammation of the 
mammary tissue is an immune reaction that occurs in response to the infection, in an attempt to 
destroy or neutralize the invasive microbes (NMC, 2002). The inflammatory response consists of 
an increase in blood proteins and white blood cells in the mammary tissue and the milk, and the 
purpose of the response is to destroy the irritant, repair the damaged-tissue, and return the udder 
to its pre-mastitis function (Harmon, 1994). 
Cows with subclinical mastitis have no visible changes in the appearance of milk or the 
udder, but milk production decreases, somatic cell count (SCC) increases, pathogens are present 
in the secretion, and milk composition is altered (NMC, 2002). Clinical mastitis is defined by 
abnormal milk, with watery appearance, presence of flakes, clots, or pus, and with varying 
degrees of mammary gland inflammation, like redness, heat, swelling, and pain. Clinical mastitis 
may or may not be accompanied by systemic illness (Tyler and Cullor, 1990). 
Cows are at highest risk of developing clinical mastitis around parturition (Smith et al., 
1985; Bradley and Green 2004; McDougall et al., 2007). The interval from two weeks before 
calving to three weeks after calving is considered to be the most critical period for the health of 
the mammary gland (Oliver and Sordillo, 1988). Furthermore, during colostrogenesis, the 
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susceptibility of the mammary gland to infections increases because the teat canal starts to open 
and can leak colostrum (Oliver and Sordillo 1988).  
2) Consequences 
Mastitis resulting from major pathogens causes considerable compositional changes in 
milk (Jones et al., 1984). The protein content is largely altered, as casein, the major milk protein, 
decreases and whey proteins increase (Kitchen, 1981). Furthermore, serum albumin, 
immunoglobulins, transferrin, and other serum proteins pass into milk because vascular 
permeability is altered (Batavani et al., 2007). Lactoferrin, which has antibacterial properties due 
to its iron-binding properties, increases in concentration. This increase is likely because of 
increased output by the mammary tissue and a minor contribution from PMN (Kawai, 1999). 
The breakdown of milk protein can occur from cows with clinical or subclinical mastitis 
due to presence of proteolytic enzymes. Deterioration of milk protein as a result of mastitis may 
continue during processing and storage (Bramley et al., 1996). Potassium, normally the 
predominant mineral in milk, is reduced. Calcium also can decrease (Batavani et al., 2007). The 
alteration on protein composition, caused by mastitis, negatively impacts the quality of dairy 
products, like yield, flavor and quality (Bramley et al., 1996, Chagunda et al., 2006, Bansal et al., 
2007). Bramley et al. (1996) explained that the dairy industry must supply milk that is free of 
antibiotics or adulterants, low in bacteria and SCC, and excellent in quality and flavor to 
maintain a positive consumer image.  Mastitis also compromises animal welfare (Chagunda et 
al., 2006, Hogeveen et al., 2011), which may further damage the image of the dairy industry to 
consumers (Hogeveen et al., 2011).  
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Enhancing environmental hygiene and improving milking techniques are typical 
measures in preventing mastitis occurrence. Blanket dry-cow therapy, or infusing antibiotics into 
all quarters of all cows at the end of the lactation, has proven to be the most effective means of 
eliminating existing infections and preventing new infections during the dry period (NMC, 
2002). Nevertheless, occurrence of clinical mastitis postpartum remains high (Smith et al. 1985; 
Bradley and Green 2004; McDougall et al. 2007). Because of the increased incidence of mastitis 
in the periparturient period, strategies that aid in mastitis prevention are needed, but currently 
lacking. Enhancing the immune response of dairy cows might represent another strategy in 
avoiding mastitis and its consequences.  
Periparturient reproductive disorders 
1) Retained placenta 
Fetal membranes, or the placenta, represent an essential organ for prenatal transfer of 
nutrients and oxygen from the dam to the fetus (Wooding, 1992).  The term placenta is borrowed 
from Latin placenta (meaning flat cake), because of the flat round shape of this organ afterbirth 
(George, 1997). The placenta functions as a fetal-maternal organ with two components: the fetal 
placenta (Chorion frondosum), which develops from the same blastocyst that forms the fetus, 
and the maternal placenta (Decidua basalis), which develops from the maternal uterine tissue 
(Peter, 2013). The release of fetal membranes postpartum is a physiological process and involves 
loss of the feto-maternal adherence, combined with contraction of uterine musculature (El-Malky 




Retained placenta (RP) is a reproductive abnormality unique to the cow and water 
buffalo among domestic ruminants (Laven and Peters, 1996). In the United States, published 
surveys (NAHMS, 2014) indicate that the incidence of RP reported for dairy cows was 4.5 ± 
0.4%. However, researchers report the incidence of RP to vary between 3 and 39% of all 
parturitions (Paisley et al., 1986; Eiler, 1997; Noakes et al., 2001). Incidence of RP is influenced 
depending on the definition utilized (Grunert, 1986, Laven and Peters, 1996).  
Grunet (1986) defined RP as failure to expel fetal membranes within 24 hours after 
parturition (Grunert 1986), although other researchers found that retention of fetal membranes 
for longer than 12 hours can be considered as pathological (Wetherill et al., 1965). Retained 
placenta delays the postpartum resumption of cyclic ovarian function and prolongs the interval 
from calving to first ovulation (Opsomer et al., 2000). Retained placenta, metritis, and 
endometritis typically result in the late involution of the uterus and late regression of the ovarian 
corpus luteum after calving.  
Causes of RP are not fully understood, but abortion (Muller and Owens, 1974), dystocia 
(Wetherill, 1965), fat cow syndrome (Markusfeld, 1987), increased parity (Markusfeld, 1987), 
twin birth, stillbirth, hypocalcemia, and increased environmental temperature (Boyd and Sellers, 
1948; Markusfeld, 1987) all can increase the risk of RP. 
Gunnink (1984) proposed an interesting theory that after calving, when the placental 
blood supply is terminated, the placenta becomes a “foreign body.” The author proposed that the 
dam’s immune system needs to recognize and attack the fetal membranes as a foreign organism 
in order to expel it. Additionally, Romaniukowa (1984) found that neutrophils from cows that 
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developed RP had a decreased response to chemo-attractants and decreased ingestion capacity. 
Kimura et al. (2014) demonstrated that cows developing RP have impaired neutrophil function.  
2) Metritis 
Metritis is often associated with retained placenta (Sheldon, 2004), caesarian sections 
(Hussain et al., 1990), twins, and stillbirths (Markusfeld, 1987). Clinical signs of metritis include 
pyrexia and fetid pus within the uterine lumen, vagina, or discharging from the vulva (Sheldon 
and Dobson, 2004). This usually occurs within the first week of calving (Sheldon, 2004) and can 
result in delayed uterine involution (Sheldon, 2004; Sheldon and Dobson, 2004).  
During pregnancy, the uterus is sterile because the vulva, vestibule, vagina, and cervix 
act as physical barriers to bacteria ascending into the genital tract (BonDurant, 1999; Sheldon, 
2004). However, when the vulva is relaxed and the cervix is dilated during and after parturition, 
environmental bacteria can contaminate the uterine lumen (Sheldon and Dobson, 2004). The 
cervix remains dilated for several days (Sheldon, 2004). Consequently, virtually all cows are 
found to have aerobic or anaerobic bacteria in the uterine endometrial tissue in the first 15 days 
after calving (Elliot et al., 1974).  
Clinical metritis occurs in up to 40% of dairy cows within a week of parturition. 
However, metritis incidence depends on the definition used. According to large survey reports, 
ocurrence of clinical signs of metritis ranges between 36 and 50% (Elliot et al., 1974; Olson et 
al., 1984). However, when metritis is defined as abnormal discharged followed by signs of 
systemic illness, like fever and anorexia, this range drops to 18.5% to 21% (Ruder et al., 1981; 
Griffin et al., 1974).  
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As an alternative classification, Sheldon et al. (2009) suggested that cows should be 
classified as having “grade 1” metritis if they have an abnormally enlarged uterus and a purulent 
uterine discharge without any systemic signs of ill health. Animals with additional signs of 
systemic illness, like decreased milk yield, dullness, and fever (rectal temperature < 39.5°C) are 
classified as having “grade 2” clinical metritis. Animals with signs of toxemia like anorexia, cold 
extremities, depression, and/or collapse should be classified as having “grade 3” metritis, which 
had been reported to have poor prognosis.  
Several health problems are associated with metritis. Metritis incidence may increase risk 
of milk fever (1 to 2 times; Curds et al., 1985), retained placenta (5 to 6 times; Erb et al., 1985; 
Erb, 1987), and displaced abomasum (3 to 4 times; Markusfeld, 1986). Furthermore, metritis 
may increase days to first service, days to conception, and reduced conception rate at first service 
by one-half when compared to cows without metritis (Erb et al., 1985; Erb, 1987).  
Unfortunately, the terms metritis and endometritis have often incorrectly been used 
interchangeably, whereas each has a clear definition. Although both metritis and endometritis are 
recognized by presence of abnormal discharge in the vulva, endometritis is a superficial 
inflammation of the endometrium, which extends no deeper than the stratum spongiosum 
(Sheldon, 2004). Moreover, clinical metritis is characterized by abnormal, fetid, purulent 
discharge leaving the vulva in the first 21 days after calving (Sheldon, 2004).  Clinical 
endometritis, on the other hand, is characterized by presence of purulent (>50% pus) uterine 
discharge detectable in the vagina 21 days or more after parturition, or mucuopurulent 
(approximately 50% pus, 50% mucus) discharge detectable in the vagina after 26 days 
postpartum (Sheldon, 2004). Endometritis incidence ranges from 10 to 20% in dairy cattle 
(Borsberry and Dobson, 1984; LeBlanc, 2002). In a Canadian study, the first service conception 
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rate was lower for cows with endometritis (29.8 versus 37.9%), the median calving to conception 
interval was longer (151 versus 119 days), and more animals were culled for failure to conceive 
(6.7 versus 3.8%; LeBlanc, 2002). Polymorphonuclear neutrophils are the main effector cells for 
removing microbes from the uterus after calving. Nevertheless, endocrine and metabolic changes 
around the time of parturition in cattle modulate PMN phagocytic function and gene expression 
(Burvenich, et al., 2007; Madsen, et al., 2002). Blood PMNs obtained from cows with 
endometritis were significantly less phagocytic (Kim and Yang, 2005).  
The immune response 
According to the National Cancer Institution, the immune system is defined as “a 
complex network of cells, tissues, organs, and the substances they synthesize that helps the body 
fight infections and other diseases.” The main purpose of the immune system is to protect an 
animal’s body from infectious disease (Parham, 2015). Infectious microorganisms that cause 
disease are called pathogens, and they can be divided into four types: bacteria, viruses, fungi, and 
internal parasites (Alberts et al., 2002). An animal’s body has successive lines of defense that 
must be overcome if a pathogen is to establish successful infection (Hoffmann et al., 1999).  
The skin is a tough barrier of epithelial cells protected by layers of keratinized cells and is 
the first physical barrier (Denda, 2000). Although tough, the skin can be breached by physical 
damage, like wounds, burns, or surgical procedures (Percival, 2002). After skin, the next 
physical defense is the epithelial lining surface of the respiratory, gastrointestinal, and urogenital 
tracts (Hoffmann et al., 1999). These surfaces are called mucosal surfaces because they are 
continually bathed in mucus (Hoffmann et al., 1999). Epithelial cells produce mucus, and mucus 
is made of glycoproteins, proteoglycans, and enzymes (Hoffmann et al., 1999). Mucus protects 
the epithelial cells from damage and help limit infection rate (Magagoli, 2016; Parham, 2015).  
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The immune system is activated when skin and mucosa are breached and pathogens gain 
access to the body’s soft tissues. The defenses of the innate and adaptive immune system must be 
activated in order to avoid a successful pathogen infection (Parham, 2015). Cells involved in the 
innate immune response include: macrophages, neutrophils, basophils, eosinophils, and natural 
killer (NK) cells (Alberts et al., 2002). Cells involved in the adaptive immune response include 
lymphocytes, like T-cells (cytotoxic and T-helper cells) and B-cells (plasma cells and memory 
B-cells) (Alberts et al., 2002). Dendritic cells and macrophages link the innate and the adaptive 
immune response (Parham, 2015).  
The adaptive immune response, or acquired immunity, is highly specific for the pathogen 
that induces them (Parham, 2015). Although it is slower to develop, the lymphocytes responsible 
for the adaptive response have memory and will provide long-lasting protection (Alberts et al., 
2002). The adaptive immune response is only present in mammals and occurs after exposure to 
an antigen either from a pathogen or vaccination (Alberts et al., 2002). When the innate immune 
response is insufficient to control an infection, the adaptive immune response is activated 
(Alberts et al., 2002).  
Acquired immunity relies on the ability of immune cells to distinguish the animal cells 
(self) and invaders microbes (non-self) (DeSilva and Clain, 2015). At the site of infection, 
dendritic cells can detect antigens, or non-self-molecules, and trigger the onset of the adaptive 
response (Parham, 2010). Dendritic cells and macrophages are professional presenting cells that 
present antigens through major histocompatibility complex (MHC) molecules (Parham, 2010). 
Through MHC molecules, dendritic cells display peptide fragments of pathogen to the cell 
surface of T-cells (Iwasaki and Medzhitov, 2005). During this interaction, dendritic cells and 
macrophages releases interleukin-1, which stimulate T-helper cell to release interleukin-2 
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(Iwasaki and Medzhitov, 2005). The function of interleukin-2 is to stimulate proliferation of 
cytotoxic T-cells and B-cells (Iwasaki and Medzhitov, 2005).   
Via MHC molecules, cytotoxic T-cells are capable of recognizing and binding with 
infected cells (Parham, 2010). Cytotoxic T-cells release chemicals that can kill infected cells 
(Medzhitov, 2007). Differently than cytotoxic T-cells, T-helper cells do not kill cells or 
pathogens (Medzhitov, 2007). Instead, T-helper cells activate B-cells and lead them to recognize 
a particular antigen (Parham, 2010). B-cells undergo successive modifications and once they can 
bind to a certain antigen, they receive additional signals from a helper T-cell and further 
differentiates into an effector cell, known as a plasma cell (Parham, 2010). Plasma cells are 
short-lived cells that may last for 5 days (Medzhitov, 2007). Plasma cells produce antibodies that 
enter the blood stream and can bind to the antigen (Parham, 2010). Nevertheless, not all B-cells 
become plasma cells. Indeed, certain B-cells become memory B-cells that may survive for 
several decades (Iwasaki and Medzhitov, 2005). Long-lived memory B-cells have the ability to 
recognize the same pathogen in case a re-infection occurs in the future (DeSilva and Clain, 
2015). These specialized B-cells make the response for a secondary immune response faster and 
more efficient (DeSilva and Clain, 2015). This powerful secondary immune response is what 
gives immunity to some diseases after the animal has had it once or after they have been 
vaccinated (DeSilva and Clain, 2015).  
The cell receptors utilized to recognize pathogens is one of the main differences between 
the innate and adaptive immune systems (Medzhitov, 2007). While acquired immune responses 
take at least 5 to 7 days to be effective after an infection occurs, the innate immune responses 
occur immediately after exposure to pathogens and serve as the first line of immune cells to 
defend the host against microbes (Alberts et al., 2002).  
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On the other side of the spectrum, certain bacteria, like Escherichia coli can double in as 
little as 20 minutes under optimal growth conditions (Gibson, 2018). Hence, a single bacterium 
can produce almost 20 million progeny in a single day (Alberts et al., 2002). Therefore, during 
the first critical hours and days of exposure to a new pathogen, animals have to rely on the 
mechanisms of innate immunity (Medzhitov and Janeway, 2000), which include antimicrobial 
peptides, phagocytes, and the alternative complement pathway. These mechanisms control the 
replication of the infecting pathogen while the adaptive response is not ready (Alberts et al., 
2002).  
The innate immune response 
The innate response, or non-specific immunity is the first natural defense against 
pathogens once they have entered the body (Alberts et al., 2002). The innate immune recognition 
is mediated by pattern recognition receptors (PRR).  Pattern recognition receptors are based on 
the detection of molecular structures that are unique to microorganisms and are not present in the 
uninfected host. These molecular structures are called pathogen associated molecular patterns 
(PAMP, Janeway, 2013). Examples of PAMP include bacterial lipopolysaccharide, 
peptidoglycans, lipoteichoic acids, mannans, and glucans (Parham, 2015). Pathogen associated 
molecular patterns are produced only by microbial pathogens, not by their hosts (Medzhitov and 
Janeway, 2000), allowing the immune cells to discriminate between non-self antigens and self-
antigens.  
Pattern recognition receptors present in the surface of innate immune cells recognize 
PAMPs on the surface of invading microbes (Parham, 2015). Macrophages that reside in tissues 
throughout the body where infections are likely to occur (like the lungs, gut, and the mammary 
gland) are the first leukocytes to detect pathogens in the tissues (Alberts, 2002). After 
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encountering pathogens, macrophages bind to microbial PAMP, promote phagocytosis, and 
digest the pathogen into small antigens (Parham, 2015). Additionally, macrophages induce 
production of inflammatory cytokines that increase permeability of local blood vessels and 
attract other immune cells to the site of infection (Medzhitov and Janeway, 2000). 
Cytokines are signaling proteins released by certain cells that affect the behavior of other 
cells (Lackie, 2010). Cytokines consist of a diversified group of small peptides synthesized by 
cells with the aim of binding to specific receptors on target cells to initiate intra-cellular 
signaling cascades (Preshaw and Taylor, 2011). Examples of cytokines include chemokines, 
interferons, interleukins (IL), lymphokines, tumour necrosis factors (TNF), and granulocyte 
colony stimulating factor (G-CSF) (Zhang and Jianxiong, 2007). Certain cytokines, like IL-β 
and TNF-α have inflammatory properties. These inflammatory cytokines cause heat, pain, 
redness, and swelling at the site of the infection (Parham 2015), and allow leukocytes, like 
neutrophils, monocytes, and NK cells to migrate from blood circulation to the site of the 
infection (Zhang, 2007).  
Natural killer (NK) cells are another type of lymphocyte that aids in the innate immune 
response (Parham 2015). Typically, NK cells do not target a specific antigen. Instead, they target 
cells with abnormal behavior, like infected cells and cancer cells (Parham, 2015). On their 
surfaces, NK cells have activating and inhibitory receptors that differentiate self-normal cells 
from infected and abnormal cells (Alberts, 2002). Natural killer cells destroy virus-infected cells 
by inducing the infected cell to kill itself by undergoing apoptosis. Unlike cytotoxic T cells, NK 
cells do not express antigen-specific receptors (Parham, 2015). 
Another important group of cells that are fundamental to the innate immune response are 
granulocytes cells.  Eosinophils, basophils, and neutrophils are the three types of granulocytes 
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(Parham, 2015). Granulocytes are a group of cells that are characterized by the presence of 
granules in their cytoplasm, and these granules are filled with proteolytic enzymes that are used 
to digest microbes once they have been phagocytized. Granulocytes are also known as PMN 
because their nuclei have an uncommon shape and are divided into different lobules (Alberts, 
2002).  All granulocytes, or PMN, originate in bone marrow. Eosinophils play an important role 
in killing internal parasites. Although these cells have a limited ability to participate in 
phagocytosis, they are professional antigen presenting cells (Gleich, 1986). Basophils are the 
least abundant granulocyte. However, they are fundamental for the immune system because they 
have the capability to travel to the site of the infection and release histamine and prostaglandin 
(Kelly et al., 2009). Histamine and prostaglandin increase local inflammation and aid in the fight 
against microbes (Kelly et al., 2009). Together with basophils and eosinophils, neutrophils are 
part of the PMN cell family. Interestingly, the term PMN often refers specifically to "neutrophil 
granulocytes" (Merriam-Webster, 2019), perhaps because neutrophils are not only the most 
abundant species of PMN, but also the most abundant type of white blood cells in mammals (60 
to 70%) (Parham, 2015). 
Elie Metchnikoff first discovered these highly motile phagocytic cells when he inserted 
rose thorns into starfish larvae and found that a group of cells accumulated at the puncture site. 
Metchnikoff observed phagocytic activity in these cells that he first named “microphagocytes,” 
now known as neutrophils (Gordon, 2008). These short-lived cells are very mobile, and have the 
ability to enter parts of tissue where other cells cannot (Borregaard, 2010). Just like other 
leukocytes, neutrophils’ behavior is dictated by cytokines. Granulocyte-colony stimulating 
factors are a group of cytokines that increase production and differentiation of neutrophils by 
progenitor cells in the bone marrow (Nomura et al., 1986; Nagata, 1989) After being released 
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from the bone marrow; neutrophils circulate in the blood stream for a few hours until they are 
attracted to infected tissue by another cytokine, CXCL-8 (Parham, 2015). Neutrophils are the 
first-responders and migrate to the site of infection in a process called chemotaxis (Alberts, 
2002). While fighting microbes, macrophages will generally survive and continue to patrol 
tissues for other pathogens (Segal, 2015), whereas neutrophils die and form pus in acutely 
infected wounds (Segal, 2005)  
Recombinant G-CSF and the innate immune suppression in dairy cows 
In the early postpartum period, bovine neutrophils have been reported to be impaired 
(Kehrli et al., 1989; Kehrli and Roth, 1989). Indeed, another study found that blood neutrophils 
from early lactation cows had greater rates of apoptosis when compared to neutrophils from mid-
lactation cows (Van Oostveldt et al., 2001) A more recent study has shown that after parturition, 
bovine neutrophils can decrease chemotaxis towards the cytokine CXCL8, which can lead to 
delayed arrival to the infection site (Graugnard et al., 2012).  
Impaired neutrophil function around the time of calving may increase the risk of uterine 
and mammary diseases (Bassel and Caswell, 2018). A better understanding of the function of 
bovine neutrophils is important to the field of dairy science, as neutrophil manipulation might 
represent a novel method of disease prevention which may improve animal health by decreasing 
the incidence of production-limiting diseases, like as mastitis and metritis (Bassel and Caswell, 
2018). 
Granulocyte-colony stimulating factors are a group of cytokines that increase production 
and differentiation of neutrophils (Nomura et al., 1986; Nagata, 1989). Generally, the term G-
CSF refers to the group of signaling proteins that stimulate cell growth, differentiation, survival, 
inflammation, and tissue repair. Similarly to other cytokine types, neighboring cells, distant 
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tissues and glands, or even tumor cells can secrete them (Nagata, 1989). In humans, the 
utilization of commercially available G-CSF in cancer patients is effective in reducing the 
incidence of febrile neutropenia (neutrophil numbers below normal values) that typically 
happens when chemotherapy is used to treat cancer (Cooper et al., 2011). The utilization of this 
artificially produced molecule is only possible because of covalent binding to large polymers, 
like polyethylene glycol, that increases the length of activity of these proteins, in a process called 
pegylation. Pegylation delays the first-pass renal clearance, and reduces proteolytic degradation 
from 3 to 5 hours to 6 to 12 days (Molineux, 2003). Interestingly, a single injection of PEGylated 
human G-CSF (pegfilgrastim) provided equivalent efficacy to 11 daily doses of non PEGylated 
hG-CSF (Molineux, 2004), which shows the effectiveness of pegylation on increasing the half-
life of this molecule by reducing its degradation. 
Similarly to other species, bovine neutrophils are produced within the bone marrow, 
when G-CSF stimulates the bone marrow to produce granulocytes and stem cells, and subsequent 
release of these cells in the bloodstream (Bassel and Caswell, 2018). Neutrophils are formed in 6 
days, but are held in the marrow for an additional day (Valli et al. 1971). The G-CSF-receptors 
are present in precursor cells in the bone marrow. In response to stimulation by G-CSF, 
precursor cells initiate proliferation and differentiation into mature neutrophils (Bassel and 
Caswell, 2018).  
Pegbovigrastim is an artificial and modified form of the naturally occurring bovine 
granulocyte colony-stimulating factor (bG-CSF), produced and commercialized as Imrestor by 
Elanco Animal Health (Elanco Animal Health, Greenfield, IN). Mononuclear leukocytes, 
endothelial cells, and fibroblasts are responsible for producing the naturally occurring bG-CSF 
that is responsible for stimulating the production and increasing activity of granulocyte cells, like 
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neutrophils (Avalos, 1996).  Pegbovigrastim is identical in the primary sequence to the 
endogenously-produced protein, except that it has an additional terminal methionine, a single 
amino acid substitution, and a novel amino acid, p-acetylphenylalanine (Figure 1.1). These 
changes in the protein structure enable site-specific covalent attachment of a 20 kDa 
polyethylene glycol polymer chain. This attachment is responsible for prolonging the activity of 
pegbovigrastim from a few hours to a few days, by slowing down its degradation inside the 
animal’s body and removal by the kidneys (Harris et al., 2001). Pegbovigrastim is FDA 
approved and was commercially available under veterinary prescription. According to the 
Imrestor label, when the product is applied subcutaneously 7 days before calving and again at the 
day of calving, Imrestor can decrease clinical mastitis incidence by 28% in the first 30 days of 
lactation in dairy cows and heifers.  
Kimura et al. (2014) explained that treatment with Pegbovigrastim greatly increased 
PMN numbers in the circulation of treated cows. After the second Imrestor injection, the PMN 
numbers increased by 435% and remained elevated through 13 days after calving when the study 
ended. In treated cows, PMN counts peaked on day 1 at 18.99 ± 2.18 million cells/ mL, followed 
by a gradual decrease. In the control group, the PMN number remained similar to baseline 
measures for −5, −2, and 1 d (4.38 ± 1.13, 4.36 ± 0.9, and 4.32 ± 2.29 million cells/mL, 
respectively). The authors theorized that the increase in PMN number should enable more PMN 
to travel to an early site of infection, such as the uterus or mammary gland and control the 
replication of the infecting pathogen until the adaptive response is ready (Kimura et al., 2014).   
In a field study conducted on 17 Mexican dairy herds by Ruiz et al. (2017), Imrestor was 
administered to dairy cows approximately 7 days before expected calving and within the first 24 
hours after calving. The incidence of clinical mastitis decreased by 25% during the first 30 DIM. 
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Moreover, the number of treatments required for mastitis was reduced and consequently less 
milk was discarded due to lesser antibiotic use. Surprisingly, clinical metritis incidence 
significantly increased by 17.1% when cows were treated with Pegbovigrastim.  
To further explore the application of pegbovigrastim under herd management systems 
typical of those found in the United States dairy industry, Canning et al. (2017) conducted a 
study at four commercial dairies in Wisconsin, Colorado, California, and Washington. In their 
study, cows exhibited a 35% decrease in the incidence of clinical mastitis compared to control 
cows during the first 30 days of lactation. The authors explained that Pegbovigrastim was well 
tolerated by cows and was not associated with changes in milk production or milk composition 
(Canning et al., 2017).  
Zinicola et al. (2018) evaluated the effects of treating Holstein cows with Pegbovigrastim 
on white blood cell count, periparturient diseases, milk production, and reproductive 
performance. They found that Imrestor treatment induced postpartum neutrophilia; however, it 
did not affect the incidence of mastitis, metritis, puerperal metritis, or clinical endometritis. On 
the other hand, when treated with pegbovigrastim, cows were 8.27 times more likely to develop 
DA, 1.79 times more likely to have lameness, and 1.39 times more likely to have any clinical 
disease during the first 30 days postpartum. Although Pegbovigrastim increased leukocyte 








Table 1.1 A partial list of the metabolic changes associated with lactogenesis in ruminants. 
Physiological 
Function 
Metabolic Change Tissues involved 










Decreased use of glucose 
General body tissues Increased use of lipids as energy 
source 
Protein metabolism Mobilization of protein reserves Muscle 
Mineral metabolism 
Increased absorption and 
mobilization 
Kidney, liver gut and 
bone 








Figure 1.1 Pegbovigrastim molecule.  
Pegbovigrastim is identical in the primary sequence to the endogenously produced protein, 
except that it has an additional terminal methionine, a single amino acid substitution, and a novel 
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EVALUATION OF PRODUCTION PARAMETERS AND HEALTH OF DAIRY COWS 
TREATED WITH PEGBOVIGRASTIM 
Abstract 
The aim of this study was to evaluate the effects of pegbovigrastim injection (Imrestor, 
Elanco Animal Health, Greenfield, IN) on production parameters and postpartum disease 
occurrence (retained placenta, metritis, displaced abomasum, and clinical mastitis) in dairy cows. 
Study cows (n = 270) were blocked by parity group (multiparous or primiparous) and randomly 
assigned to control (CON, n = 144) or pegbovigrastim treatment (IMR, n = 126). Ten ± 4 d 
before expected calving and again at calving, IMR cows received subcutaneous injection 
containing 2.7 mL of Imrestor and CON cows received 2.7 mL of 0.9% saline. Milk yield, fat, 
protein, lactose, solids nonfat percent, and SCC, body condition, hygiene, and lameness were 
evaluated weekly. Animals were evaluated for metritis twice weekly through rectal temperature, 
palpation, and uterine discharge evaluation until 30 DIM. Farm personnel recorded other 
postpartum diseases. The MIXED procedure of SAS was used to evaluate milk composition and 
milk yields were analyzed as repeated measures in time with block, treatment, calving month, 
and lactation week included in mixed models. The GLIMMIX procedure was used to evaluate 
mastitis and metritis occurrence. Variables entered a model if P ≤ 0.10 when screened 
individually. Variables with P ≤ 0.10 were kept in the final model. Milk yield, fat, protein, 
lactose, solids-non-fat (SNF), and log of somatic cell count (SCC) were not significantly affected 
by treatment. Clinical mastitis occurrence did not differ between treatments, but only 17 cases 
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were detected. Although treatment did not increase puerperal metritis occurrence, treated cows 
were 2.46 times more likely to develop clinical metritis when compared to control cows. Cows 
given pegbovigrastim injections had increased odds of developing clinical signs of metritis, but 
no negative effects on milk production and composition were observed.  
Keywords: Imrestor, mastitis, metritis 
Introduction 
The leading cause for involuntarily culling of dairy cows in the United States is udder 
and mastitis problems, followed by reproductive disorders (USDA, 2007). More animals are 
involuntarily culled in the first 30 DIM than in any other period (Fetrow et al., 2006). Clinical 
mastitis in the first 30 DIM costs an average of $444 per case (Rollin et al., 2015). 
Environmental and contagious bacteria constantly challenge the mammary gland of dairy cows, 
but cows are more susceptible to mastitis after calving (Kimura et al., 1999). Additionally, when 
the vulva is relaxed and the cervix is dilated during and after parturition, environment bacteria 
can contaminate the uterine lumen, increasing the risk of metritis (Ruder et al., 1981). 
Periparturient mastitis and metritis susceptibility in dairy cattle is related to the generalized 
immune suppression that occurs from approximately one week pre- to one week postpartum 
(Kehrli et al., 1989; Burton et al., 2003).  
Polymorphonuclear neutrophils (PMN) are the predominant white blood cell type found 
in mammary tissues during acute inflammation, representing 90% or more of total mammary 
gland leukocytes during the time of infection (Paape et al., 1979). Unfortunately, white blood 
cells are impaired at the time of calving (Kimura et al., 1999) and the ability of PMNs to engulf 
and kill bacteria decreases gradually starting around two weeks before expected calving, 
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reaching nadir at calving, and slowly increasing two to four weeks after parturition (Kehrli et al., 
1989).  
Pegbovigrastim is a modified form of the naturally occurring bovine granulocyte colony-
stimulating factor (bG-CSF). At the time of the study, pegbovigrastim was commercially 
available under veterinary prescription as Imrestor (Elanco Animal Health, Greenfield, Illinois).  
According to the product label, when the product is administered 7 days before calving and again 
at the day of calving, clinical mastitis (CM) incidence decreases by 28% in the first 30 days of 
lactation in dairy cows and heifers. Although some researchers have found a 35% decrease 
(Canning et al., 2017) or a 25% decrease (Ruiz et al., 2017) incidence of clinical mastitis when 
cows and heifers were treated with Imrestor. 
When Imrestor was administered to dairy cows approximately 7 d before expecting 
calving and again at calving, the incidence of signs typically associated with clinical metritis 
increased by 17.1% when compared to untreated cows, whereas the odds of control cows having 
metritis was 16% less (Ruiz et al., 2017).  Metritis is a severe inflammatory reaction involving 
all layers of the uterus including the endometrial mucosa and submucosa, muscularis, and serosa 
(Bondurant, 1999). Clinical signs of metritis include pyrexia, fetid pus within the uterine lumen, 
vagina, or discharging from the vulva, and delayed uterine involution (Sheldon et al., 2004). In 
contrast to clinical metritis, puerperal metritis is characterized by an acute systemic illness that 
often results in fever, reduced milk yield, dullness, inappetence, and anorexia (Sheldon et al., 
2006). Imrestor could potentially affect the number of PMNs called to the uterus post-calving 
similarly to what its label claim is for mastitis. 
The objective of this study was to test effectiveness of Imrestor at reducing CM 
incidence, and to evaluate disease incidence (clinical metritis, retained placenta, displaced 
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abomasum) in the first 30 days of lactation on a commercial dairy operation.  The hypothesis 
tested was that periparturient dairy cattle treated with Imrestor will display difference in disease 
incidence.  Additionally, production parameters (milk production and components) and SCC 
were measured to evaluate differences between Imrestor-treated cows and control cows. 
Material and Methods 
This randomized controlled trial was conducted on 270 Holstein cows at a commercial 
dairy farm in Senatobia, Mississippi from August 7, 2017 to March 31, 2018. The experiment 
was designed as a randomized complete block, with two treatment groups and two blocks.  
Primiparous cows (n = 98) were all assigned to block one and multiparous (n = 172) were 
assigned to block two. Within each block, cows were randomly assigned to one of the two 
treatments:  Imrestor (IMR, n = 126) or control (CON, n = 144). Animals were randomly 
assigned to treatments using the random number generator function within Dairy Comp 305 
(Valley Agricultural Software, Tulare, CA). The randomization procedures were repeated 
monthly, and the designated treatment assignment was inspected to ensure that the distributions 
between the two treatments groups were similar for the predicted 305-day milk production for 
multiparous cows. If the 305-day milk production were not similar, the randomization procedure 
was redone until similar production across treatments was achieved. Cows were enrolled in the 
trial starting on August 7, 2017 until January 31, 2018.  
Before the study start, a power analysis was conducted in SAS version 9.4 (Cary, North 
Carolina) to estimate the sample size. A mean difference of 1.25 kg of milk/day was tested 
because it is the increase in milk a cow would need to produce daily in order pay for the product. 
In Mississippi, producers received $17.97/cwt in April 2017 and the product cost 
$30/animal/lactation. Previous farm data indicated milk production was normally distributed 
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with a standard deviation of 10.35 kg/day. Assuming a power of 0.8 and a type I error associated 
with the null hypothesis being 0.05, the necessary amount of animals per treatment was 1061.  
To facilitate data collection, each study animal received a leg bend to distinguish them 
from non-study animals. In order to avoid possible bias, the second author performed all 
randomization procedures but did not participate in on-farm data collection and only shared the 
information with the farm manager, who applied the treatments and thus needed to know the 
assignments. Farm employees and the other authors did not know which animals belonged to 
which treatment at the time of the study. 
Anticipated calving dates were determined by farm breeding records. Ten ± 4 days before 
expected calving and again within 24 hours after calving, IMR cows received Imrestor (15 mg; 
2.7 mL; single pre-filled syringe) and CON cows received saline (2.7 mL of 0.9% of sodium 
chloride). Both IMR and saline treatments were given subcutaneously in the neck, using a 3/4” x 
18-gauge needle.  On a weekly basis, farm personnel gathered animals that were 10 ± 4 days 
from their expected calving date and applied treatments. Injections were given on the same day 
and approximately the same time each week. Although the product label states that the first IMR 
injection should be given 7 days before expected calving, past farm records were evaluated and 
the authors expected animals to calve early during hot summer months (June, July, August, and 
September). Therefore, 10 days before expected calving was chosen for this study in an attempt 
to prevent removing cows from the study due to calving before the first injection was 
administered.  
Animal husbandry  
The Mississippi State Institutional Animal Care and Use Committee (IACUC-17-364) 
approved the study protocol. Dry cows were housed in two separate groups based on days in 
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gestation: far-off (225 to 262 days of gestation; pasture) and close-up (≥ 263 of gestation; 
confinement). Close up cows received TMR consisting of 45% forage and 55% concentrate on a 
dry matter basis. The diet was formulated by the farm’s hired dairy nutritionist to meet or exceed 
the NRC nutrient requirements for dry Holstein cows weighing 650 kg (NRC 2001).  
Farm employees were responsible for checking the close-up barn multiple times per day 
to find newborn calves and to help cows with dystocia.  They were trained to identify and report 
calving scores for each cow at calving, where 1 represented a normal birth without assistance; 2 
represented a slight problem with mild human intervention; 3 represented moderate assistance, 
requiring introduction of arm into the vagina; 4 represented major assistance, requiring 
mechanical extraction; and 5 represented a surgical extraction (Lombard et al., 2007). Farm 
personnel relied on experience to determine when interventions were necessary. Calving scores 
were recorded in Dairy Comp 305 after each calving. Calves were removed from the maternity 
pen immediately after birth and were placed in a straw-bedded pen. Cows were moved to one of 
two deep-bedded, sand free-stall barns, primiparous in one and multiparous in another. Lactating 
cows were offered ad libitum access to water and TMR consisting of approximately 43% forage 
(corn silage) and 57% concentrate (wet brewers grains, soybean meal, ground corn, cottonseed 
meal) on a dry matter basis. Cows were fed twice a day, after the morning and the afternoon 
milking. Feed was mechanically pushed up three times daily.  
Data collection 
Once a week, study cows were assigned a score for body condition (BCS), locomotion 
(LOC), and hygiene (HYG). These three measurements were collected starting 14 days before 
expected calving date to 60 DIM. Body condition was evaluated on a 5-point scoring system, 
with quarter point increments, where 1 represented very thin; 2 represented thin; 3 represented 
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moderate condition; 4 represented well-conditioned; and 5 represented over-conditioned 
(Edmonson et al., 1989). Locomotion score ranged from a 1 to 3, where 1 represented normal 
locomotion, no observed difficulty when walking; 2 represented moderately lame, with a slightly 
abnormal gait and moderately arched back during the walk, and 3 represented severely lame, 
standing and walking with an arched back, with great difficulty walking or moving from lying 
position (NAHMS and USDA, 2007). Udder hygiene scores ranged from 0 to 3, where 0 
represented no manure present; 1 represented presence of fresh manure in less than 50% of the 
rear udder area; 2 represented presence of fresh manure in more than 50% of the rear udder area; 
and 3 represented presence of dry caked manure in more than 50% of the rear udder area, as 
previously described (Schreiner and Ruegg, 2002). 
Composite udder milk samples were obtained for each study cow to assess milk 
composition weekly. Automatic milk weights were not available in the parlor so these were also 
obtained weekly. These measurements were taken from first sample day milking post-parturition 
(1 to 7 DIM) until each cow reached the last week before completing 60 DIM (52 to 59 DIM). 
Waikato milk lines (Waikato Milking Systems, Horotiu, New Zealand) were installed in each 
milk unit to collect a milk sample and to measure milk yield. Before sampling milk, air was 
allowed to enter the system for approximately 10 seconds to allow proper homogenization the 
each sample. Samples were placed in a plastic vial containing an 8 mg tablet of bronopol (2-
bromo-2-nitropropano-1, 3-diol) utilized to delay microbial growth. Samples were kept over the 
weekend at room temperature until they were sent to Mid-South Dairy Records (Springfield, 
MO) for analysis of fat, protein, lactose, solids non-fat (SNF) (%), and SCC (cells/ml).  
Each morning, before attaching the milking units, milkers forestripped each quarter of 
each cow and observed the general milk and udder appearance. Before the study started, all 7 
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milkers were trained to identify and score clinical mastitis using a scale from 1 to 3 (Table 1). 
This information was recorded for each clinical case until cows reached 60 DIM. 
During their first 30 DIM, study cows were palpated twice a week to evaluate clinical 
metritis status. The farm visits were scheduled so that the veterinarian of record (VOR) visited 
the farm at least once every two weeks. A palpation chart was developed by the VOR (Table 2) 
based on clinical experience, and the graduate student managing this project was trained to 
perform the health checks by the VOR. In the absence of the VOR (every other week), the 
graduate student performed the health evaluations. In each health check, uterine tone and vaginal 
discharge were evaluated. Presence of watery, reddish-brown or white and purulent, fetid odor 
discharge was used to define clinical metritis. In addition, rectal temperature (RT) and rectal 
palpation of the uterus were performed to aid in puerperal metritis recognition (Sheldon et al., 
2006). Presence of abnormal discharge along with fever (RT above 40℃ over summer and fall, 
or 39.7 ℃ during winter) were the cut points for puerperal metritis. 
Results and discussion 
The intervals between the first dose of Imrestor and actual calving date are displayed in 
Figure 1. On average, cows received the injection 8.46 ± 5.24 days before calving, with a range 
of 27 days. A total of 52 cows (19.26%) received their second injection within 0 to 3 days after 
the first injection; 132 (49.63%) received their second injections 4 to 10 days after their first 
injection; and 84 cows (31.1%) received their second injection more than 10 days after they 
received their first.  
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Effect of IMR in milk production and SCC 
The model to determine milk yield in CTL and IMR cows accounted for effects of block 
(P < 0.01), lactation week (P < 0.01), and calving month (P = 0.04) (Table 3). Treatment and 
block did not interact to affect MY (P = 0.30); therefore, the interaction effect was excluded from 
the final model. The effect of block was significant, and milk production was decreased in 
primiparous cows compared to multiparous cows (36.87 ± 0.91 and 44.67 ± 0.69 kg, 
respectively). Treatment was not associated with a change in MY (P = 0.62). These results are in 
agreement with previous research that also did not detect change in MY in the first 30 DIM when 
cows were treated with Imrestor or a sterile saline control (Canning et al., 2017). As expected, 
milk production increased over the 8 weeks following parturition (Figure 2). Effect of calving 
month was also significant (P < 0.01). Cows that calved in the summer months had lesses milk 
production compared to cows that calved in winter months (August with 37.85 ± 1.65 kg; 
September 39.35 ± 1.38; October 38.45 ± 1.11 kg; November 38.98 ± 1.21 kg; December 40.55 
± 1.60 kg; January 43.57 ± 1.69 kg).  
The model to determine SCC in CTL and IMR cows accounted for block (P = 0.87) and 
lactation week (P < 0.01). Weekly mean SCC in the first eight weeks of lactation is shown in 
Figure 3. No significant differences in the log of SCC on CON and IMR cows were observed (P 
= 0.21). These results indicate that despite the pronounced increase in the number of circulating 
neutrophils in the blood typically observed following pegbovigrastim-treatment (Kimura et al., 
2014; Zinicola et al., 2018), SCC does not increase in the milk. These results are of great 
importance given the important role of milk SCC in assessing milk quality. Furthermore, these 
results are consistent with the findings of Canning et al. (2017), who observed no significant 
differences in SCC between IMR and saline treated cows.  
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Animals treated with IMR also produced milk with similar composition to the saline-
treated CTL, milk fat, protein, lactose, and SNF percentages did not significantly differ (P = 
0.35, 0.24, 0.48, and 0.34, respectively; Table 2 and Figure 4). Effect of block (P < 0.01, 0.01, 
0.01, and 0.61), lactation week (P < 0.01, 0.01, 0.01, and 0.01), and calving month (P < 0.01, 
0.01, 0.01, and 0.01) were included in the fat, protein, lactose, and SNF models. 
Overall, the results found in the present study are in accordance with results found in 
previous studies, where no significant changes were observed in MY, components, and SCC 
between pegbovigrastim-treated cows with non-treated cows (Ruiz et al., 2017) or placebo-
treated controls (Hassfurther et al., 2015; Canning et al., 2017). These results indicate consistent 
proof that pegbovigrastim treatment is capable of enhancing neutrophil activity without 
negatively impacting performance of dairy cows. 
Effects of pegbovigrastim on disease occurrence  
The frequency and percent of clinical disease(s) within study cows is shown in Table 4. 
Clinical metritis occurred often in both treatment groups and very few cows had one disease by 
itself not accompanied by clinical metritis. While deciphering if treatment altered fresh cow 
disease, a new variable combining all fresh cow disease (including displaced abomasum, retained 
placenta, and mastitis) were created.  
Administration of pegbovigrastim has been associated with decreased CM incidence, but 
no significant difference was observed between the IMR and CTL groups in the present study (P 
= 0.54). However, CM occurrence was infrequent in both treatments.  Of the 270 cows in the 
study, only 17 CM cases were detected (10 IMR cows and 7 CON cows), corresponding to only 
6.41% of all study cows. These results are in conflict with a previous study conducted in 
different regions of the U.S. (Wisconsin, Washington, Colorado, and California), where 
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researchers reported that cows that received pegbovigrastim exhibited an average decrease of 
35% in the incidence of CM (P < 0.01, 122 detected cases of CM) relative to the controls during 
the first 30 days of lactation (Canning et al., 2017). Additionally, in a multi-site study conducted 
in Mexico, Imrestor reduced the incidence of mastitis by 25% (P < 0.01, 442 detected cases of 
CM), whereas the odds ratio of developing mastitis in the first 30 DIM were 35% greater for 
control cows than for Imrestor cows (P < 0.05) (Ruiz et al., 2017). Nevertheless, these results are 
similar to a study that was conducted in New York, where IMR treatment did not affect CM 
occurrence (P = 0.18) (Zinicola et al., 2018). In this recent study, the reported incidence of CM 
in the control group was 4.26% (n = 423), similar to the 4.86% found in the present study. 
Therefore, in these two studies, IMR treatment did not prevent mastitis. Zinicola et al. (2019) 
reported numerically more CM in the IMR group than in the CTL group, in concurrence with 
this study. Interestingly, although IMR treatment increases circulating levels of neutrophils, 
recent studies have reported that the neutrophil phagocytic activity, oxidation burst, and 
myeloperoxidase function is not altered by IMR treatment (Kimura et al., 2014; McDougall et 
al., 2017). Hence, it is possible that the prevention of CM is also related to activity of neutrophils 
rather than an increase in neutrophil number. Additionally, IMR treatment did not affect 
displaced abomasum, and combination of diseases (P = 0.16 and 0.12). Imrestor treated cows 
tended to have greater retained placenta (P = 0.09). 
The frequency and percentage of different uterine scores and occurrence of clinical 
metritis is presented in Table 5. Statistically, IMR treated cows displayed decreased incidence of 
uterine score 0 (CON = 40 and IMR = 16) and increased occurrence of uterine score 2 (CON = 
46 and IMR = 62). The final model to predict clinical metritis occurrence contained effects 
treatment (P < 0.01) and block (P = 0.69). Imrestor cows had a 25% greater incidence of clinical 
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signs of metritis (P < 0.01) and were 2.46 more likely to develop the disease (P < 0.01, with a 
95% confidence interval ranging from 1.41 to 4.31, Table 6). The increase in clinical metritis 
occurrence in this study is in agreement with Ruiz et al. (2017), who observed that 
administration of pegbovigrastim resulted in greater incidence of metritis (17.6%) and greater 
odds (16.4%) of developing metritis in the first 21 days after calving (P = 0.01). 
Most dairy cattle are affected by bacterial contamination in the uterus following calving 
(LeBlanc et al., 2011). Therefore, it is logical that an innate immune response following 
contamination will occur. A rise in PMN numbers following IMR administration would likely 
lead to the development of more purulent discharge, increasing the detectability of clinical 
metritis. In this study, metritis status was evaluated twice a week via rectal palpation of the 
uterus and visual observations of uterine discharges. When consistently looking for a disease, 
one is more likely to find it. Therefore, the VOR and graduate student could have detected even 
mild cases of clinical metritis. Sheldon et al. (2006) reported general clinical metritis incidence 
of 25 to 40%, which is less than the 46.5% found in this trial. 
Conclusion 
The first objective of this study was to test effectiveness of Imrestor at reducing CM 
incidence. There was no effect of treatment on CM. Additionally, no negative effects on milk 
production or components were observed between treatments. The second objective was to 
evaluate disease incidence (clinical metritis, retained placenta, displaced abomasum) in the first 
30 days of lactation. The hypothesis tested was that periparturient dairy cattle treated with 
Imrestor will display differences in disease incidence. Cows given pegbovigrastim injections 
around the time of calving had increased odds of developing clinical signs of metritis, although 
occurrence of puerperal metritis did not significantly increase. The increased odds of developing 
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clinical signs of metritis in IMR cows is concerning and should be studied in more detail to 
























Table 2.1 Clinical mastitis scoring system: cows exhibiting abnormal quarter, milk or a 
combination of both were recorded 
Clinical 
score 
Appearance of milk Appearance of quarter 
Appearance of 
the cow 
0 Normal Normal Normal 
1 
Abnormal (flakes, 




flakes, clots, or 
discoloration) 
Abnormal (sights of 
inflammation/swelling, 




flakes, clots, or 
discoloration) 
Abnormal (sights of 
inflammation/swelling, 













Table 2.2 Clinical metritis scoring system used to evaluate disease status in cows treated 





Uterus is in adequate size and tone, and clean discharge 
relative to DIM 
1 
Poor tone, flaccid, no ruggae formation, presence of fluid after 
14 DIM 
2 
Abnormal discharge (watery reddish-brown or white and 
purulent, fetid odor) 
3 
Presence of abnormal discharge and fever (rectal temperature 
> 40℃ over the summer or 37.7 ℃ during fall and winter2) 
10 to 5 DIM: Ruggae should develop on palpation of uterus, with clear increase in tone when 
palpated via rectum, with thick, viscous, clear, straw-colored discharge; 6 to 13 DIM: Tone is 
smooth leathery, it should return to normal position upon pinch.  Discharge is be thick viscous, 
more likely to be clear, straw-colored, red tinge; 14 DIM: Both horns are palpable with no fluid 
present in the uterus; 15 to 30: Muscular tone, with no discharge. 








Table 2.3 Mean of production parameters, somatic cell account, general scores, and average rectal temperature in cows treated 
with Imrestor or saline on a commercial Mississippi herd. Effects of block, month of calving, lactation week and 


















1Month of calving (ranging from August, 2017 to January, 2018) 
2Lactation week (ranging from week one until week eight after calving) 
3 Injection interval (0 = shot interval from 0 to 3 days, short interval; 1 = shot interval from 4 to 10 days;  2 shot interval greater than 
10 days) 
4Significant interaction between block and lactation week (P < 0.01) 




CTL IMR Treatment  Block Month Fresh1 LW2 Injection Interval3 
Milk yield (kg) 41.04 40.54 0.67 < 0.01 0.02 < 0.01 0.08 
Energy corrected milk (kg) 38.23 37.45 0.49 < 0.01 < 0.01 < 0.01 0.10 
Fat (%) 3.67 3.61 0.34 < 0.01 < 0.01 < 0.01 0.40 
Protein (%) 2.95 2.97 0.49 < 0.01 < 0.01 < 0.01 0.11 
Lactose (%) 4.95 4.95 0.88 < 0.01 < 0.01 < 0.01 0.24 
SNF (%) 8.85 8.87 0.61 0.59 < 0.01 < 0.01 0.21 
Log of SCC 2.71 2.77 0.34 0.84 NS5 < 0.01 0.78 
Fat (kg) 1.50 1.46 0.37 < 0.01 < 0.01 < 0.01 0.19 
Protein (kg) 1.20 1.18 0.73 < 0.01 NS < 0.01 0.05 
Lactose (kg) 2.02 2.01 0.82 < 0.01 0.06 < 0.01 0.03 
Body condition score 2.85 2.89 0.38 <0.01 <0.01 < 0.01 0.56 
Walking score 1.21 1.14 0.07 <0.01 0.04 0.04 0.74 
Hygiene score 0.29 0.28 0.86 0.07 NS5 0.54 0.37 
Rectal temperature (°C)4 39.01 38.96 0.10 < 0.01 < 0.01 < 0.01 0.19 
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Table 2.4 Frequency and percentage of clinical diseases on cows treated with Imrestor or 
saline on commercial Mississippi herd. 
Disease 
incidence  


















7 4.9  10 7.9 0.44 
Retained 
placenta 
4 2.8  14 11.1 0.09 
Displaced 
abomasum  
1 0.7  4 3.2 0.16 
Combination 12 8.3   26 20.6 0.12 
1Normal uterus; no metritis.  
2Poor uterine tone; no metritis.  
3Metritis.   










Table 2.5 Frequency and percentage of clinical metritis occurrence by category in study 






Control  Imrestor 
Frequency Percent  Frequency Percent 
0 40 28.7  16 13.11 0.02 
1 47 33.1  36 29.51 0.28 
2 46 32.39  62 50.82 0.03 
















Table 2.6 Point estimate, standard error, P-values, and confidence intervals associated with 
metritis occurrence in dairy cows that were treated with Imrestor or saline on a 
commercial Mississippi herd. 
Parameter Estimate2 SE P-value 95% CI3 
Treatment      
Control Ref. - - - 
Pegbovigrastim 2.46 0.65 < 0.01 1.41 to 4.31 
Parity     
Primiparous Ref. - - - 
Multiparous 1.65 0.82 0.69 0.13 to 20.72 
1Clinical metritis cut point was the presence of abnormal, watery reddish-brown or white and 
purulent, and fetid odor discharge 
2Point estimate of odds ratio for developing metritis;  









Figure 2.1 Days from first subcutaneous administration of Imrestor (Elanco Animal Health, 















































Figure 2.2 Effect of Imrestor on milk (mean ± SE kg) in the first 8 weeks of lactation of 

































Figure 2.3 Effect of Imrestor on fat in milk (mean ± SE %) in the first 8 weeks of lactation of 

























Figure 2.4 Effect of Imrestor on protein in milk (mean ± SE %) in the first 8 weeks of 
































Figure 2.5 Effects of Imrestor on lactose in milk (mean ± SE %) in the first 8 weeks of 
































Figure 2.6 Effect of Imrestor on lactose in milk (mean ± SE %) in the first 8 weeks of 
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EVALUATION OF REPRODUCTION AND BEHAVIOR PF DAIRY COWS TREATED 
WITH PEGBOVIGRSTIM 
Abstract 
The aim of this study was to evaluate the effects of pegbovigrastim injection (Imrestor, 
Elanco Animal Health, Greenfield, IN) on behavior and time to first detected heat. The study was 
conducted on a commercial Mississippi dairy from August 21, 2017 to March 31, 2018. Initially, 
a total of 270 cows were blocked by parity group (multiparous or primiparous) and randomly 
assigned to control (CON, n = 144) or treatment (IMR, n = 126). Study animals were equipped 
with smart leg and smart neck tags (Nedap, the Netherlands). Ten ± 2 d before expected calving 
and again at calving, treated cows received 2.7 mL of Imrestor and CON cows received 2.7 mL 
of 0.9% saline. Cows were body condition (BCS), hygiene (HYG), and lameness (LAM) scored 
weekly. The Nedap system created heat alerts based in individual behavior changes. Weekly 
summations of number of steps, time spent lying down and walking (min) was then utilized to 
determine weekly means of these variables since calving until 60 DIM. Unfortunately, because 
of malfunction in the data synch between tags and the farm software, data from only 61 cows 
were utilized in the analysis (CON = 43 and IMR = 18). The MIXED procedure of SAS was 
utilized to compare the leg activity, walking time, and lying time between the two treatment 
groups. The mixed models included fixed effects of treatments and block, and random effect of 
cow within block. A Cox proportional hazards regression was used to determine the relative 
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likelihood of cows displaying estrus within their first 60 DIM. Imrestor treatment did not alter 
the hazard ratio of estrus occurrence during the first 60 DIM (hazard ratio = 0.99, 95% CI = 0.84 
to 1.7, P = 0.88). The median calving-to-first detected heat interval for IMR and CTR cows was 
47 and 46 d, respectively (P = 0.45). Imrestor treatment did not affect time spent lying, walking, 
or amount of steps given (P = 0.54, 0.59, and 0.48, respectively). In conclusion, IMR treatment 
did not affect the behavior or time to first detected heat in study cows. 
Introduction 
Heat detection is critical to breeding programs; particularly artificial insemination and 
embryo transfer programs. The most accurate sign of estrus is when a cow is standing to be 
mounted, although secondary signs like mounting other cows, vaginal mucus discharge, swelling 
of the vulva, and restlessness can also aid in estrus detection (Allrich, 1993). 
Mean yearly estrus detection rate in U.S. Holstein herds is reported to be 44.9% in 2015 
(DRMS, 2015). This low estrus detection rate may be a consequence of the great decline in the 
duration of estrus in Holstein cattle, from 18 to less than 8 hours, over the past 50 years (Reames 
et al., 2011). Additionally, estrus assessments are subjective, time consuming, and accompanied 
by wide variation of external signs among dairy cows that requires practice and expertise by the 
human observer (Senger, 1994). 
Potential advantages of precision dairy monitoring technologies include increased 
efficiency, early detection of disease with consequent reduced disease costs, and improved 
animal well-being. Parameters monitored by these technologies include daily milk yield, milk 
components, behavior (number of steps given, lying, walking, eating, and ruminating time), 
temperature (in various places on and in the cow like rumen and ears), milk conductivity, daily 
body weight, rumen pH, blood or milk progesterone levels, and others (Bewley, 2010). All these 
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parameters can also be utilized to detect estrus activity in cows and determine adequate time of 
insemination (Dolecheck et al., 2015). 
On top of these advantages, technologies provide new opportunities to examine animals 
without observer interference. In turn, they can be used to gain an increased understanding of 
physiological and management factors that influence dairy cattle behavior. Behavioral 
observations of animals that are treated with novel products, such as Imrestor (IMR, Elanco 
Animal Health, Greenville, IN), can provide further evidence of the effectiveness of the product 
or could potentially explain hurdles that must be overcome in order for the product to be 
effective. 
Pegbovigrastim, the main component of IMR, is a modified form of the naturally 
occurring bovine granulocyte colony-stimulating factor. When administered at the time of 
calving, this protein is capable of increasing the number and activity of polymorphonuclear 
neutrophil (PMN) (Kimura, 2014). Because of the immune modulating effect caused by IMR, 
decreased clinical mastitis incidence was reported to decrease by 35% in the first 30 days of 
lactation in dairy cows and heifers (Canning, 2017).  
The objective of this study was to test the effectiveness of IMR-treated cows in returning 
to their normal uterine function, assessed by days to first detected heat. Periparturient dairy cows 
from a commercial dairy herd in Mississippi treated IMR were expected to be more equipped to 
counteract natural infection with metritis pathogens due to heightened function of the innate 
immune system. They were thus expected to display greater days to first detected heat when 
compared to placebo-treated cows. This hypothesis arose because past studies have found that 
IMR-treated cows displayed a significant increase in metritis incidence (17.1%; Ruiz et al., 
2017). Further objectives of interest were to assess some behavioral parameters (time spent lying 
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down, walking, and number of steps) that are used to identify estrus, and compare them between 
IMR- and CON-treated cows. 
Material and methods 
This study was conducted on 270 Holstein cows at a commercial dairy farm in Senatobia, 
Mississippi, from August 7th, 2017 to March 31st, 2018.  The study was designed as a 
randomized complete block, with two treatment groups and two blocks.  Primiparous cows (n = 
98) were all assigned to block one, and multiparous (n = 172) were assigned to the second block.  
Within each block, cows were randomly assigned to one of the two treatments:  IMR (n = 
126) or control (CON, n = 144). The randomization procedure was done in Dairy Comp 305 
(Valley Agricultural Software, Tulare, CA). The randomization procedures were repeated 
monthly, and designated treatment assignment was inspected to ensure that the distributions 
between the two treatments groups were similar for the predicted 305-day milk production for 
multiparous cows each month. If the 305-day milk production were not similar, the 
randomization procedure was redone until similar production across treatments was achieved. 
Cows were enrolled in the trial during multiple months of the experimental period (starting on 
August 7, 2017 until January 31, 2018). Hence, animals calved and joined the trial in different 
seasons of the year (total of 32 weeks).  
Ten ± 4 days before expected calving and again within 24 hours after calving, treated 
cows received Imrestor (15 mg; 2.7 mL; single pre-filled syringe) and control cows received 
saline (2.7 mL of 0.9% of sodium chloride). Anticipated calving dates were determined by farm 
breeding records. On a weekly basis, farm personnel gathered animals that were 10 ± 4 days 
from expected calving date to apply the treatments. Injections were given on the same day and 
time each week. Both treatments were given subcutaneously in the neck, using a 3/4” x 18-gauge 
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needle.  A total of 24 cows calved more than 14 days before their expected calving date, and 
never joined the trial because they never received their first injection. 
In the same day of the first injection date, a neck tag and a leg tag, each with activity 
monitoring sensors (Nedap Livestock Management, Groenlo, the Netherlands) was attached to 
the neck and hind left leg of each study animal. Neck tags were positioned loosely on each cow’s 
neck so that a sideways hand’s width could fit between the cow’s neck and the strap, in 
accordance with manufacturer’s instructions. The leg tags were placed tightly enough to avoid 
them falling below the dewclaws, but not tight enough that the cow was unable to comfortably 
move, also in accordance with manufacturer’s instructions. 
Technology management 
The Nedap COWcontrol ™ system (Nedap Livestock Management, Groenlo, The 
Netherlands) is composed by the leg, and neck tags together with a process controller, that 
receives the data from each tag and uploads it on the Nedap Velos System. The farm contained 
two processes controllers, one by the milking room, and close to the lactation pens, and the 
second by the dry-cow barn.  
The leg tag measured lying time, standing time, and activity with a three-axis 
accelerometer (on a 15 minutes basis). The neck tag measured time spent ruminating, eating, 
inactive, or other activity (in seconds).  
There was not a fixed threshold for the creation of heat alerts, because every cow is not 
equally active. Instead, variation in the normal activity of individual animals was utilized to 
generate alerts. The system automatically calculates alerts by dividing a day in periods of two 
hours, and in two-hour-period, each cow activity is measured. The mean and the standard 
deviation (SD) of the same two-hour-period in the previous 10 days are defined. Then, the 
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activity of a certain period minus this mean, is divided by the previously mentioned SD, the 
outcome is the increase factor. There is an increased activity during this period if the increase 
factor is > 1.5. A heat attention (recorded as a 1 in the dataset) is given if the increase factor is > 
1.5 for three consecutive two-hour-periods and if the mean of the increase factor of these three 
periods is > 3.0. A suspicious attention (recorded as a 2 in the dataset) is given if the increase 
factor is > 1.5 for two consecutive periods. According to Nedap, the latter is a more sensitive but 
a less specific method; therefore, only heat attentions (recorded as a 1 in the dataset) were 
utilized in this study.  
Farm personnel were responsible for visually checking technologies on a weekly basis, 
and adjusting the tags if they were too loose or tight. Lost tags were recovered and placed back 
on the same animal. 
Because the amount of tags supplied were not enough to assign tags on all enrolled cows 
for the duration of the study period, tags were removed from study cows and reassigned to new 
study cows entering the pre-fresh period as needed. The removed tags were reassigned and 
attached to other study cows ≥ 14 days prior to expected calving. 
Data Collection 
Once a week, study cows were assigned a score for body condition (BCS), locomotion 
(LOC), and hygiene (HYG). These three measurements were taken starting 14 days before the 
expected calving date until cows reached 60 DIM. Body condition was evaluated on a 5-point 
scoring system, with quarter point increments, where 1 = very thin; 2 = thin; 3 = moderate; 4 = 
well conditioned; and 5 = over-conditioned. The areas of interest for evaluation of quarter point 
increments were hooks, pins, point of thurl, tailhead ligaments, and sacral ligaments as proposed 
by Wildman et al., 1982.  
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Locomotion score ranged from a 1 to 3, where 1 represented normal locomotion, no 
observed difficulty when walking, and all feet placing the floor purposely; 2 represented 
moderately lame, with a slightly abnormal gait and moderately arched back during the walk, and 
3 represented severely lame, standing and walking with an arched back, with great difficulty 
when walking or moving from lying position.  
Udder hygiene scores ranged from 0 to 3, where 0 represented no manure present; 1 
represented presence of fresh manure in less than 50% of the rear udder area; 2 represented 
presence of fresh manure in more than 50% of the rear udder area; and 3 represented presence of 
dry caked manure in more than 50% of the rear udder area. 
Milk yield was recorded and milk samples were obtained to assess composition for each 
cow’s milk weekly. These measurements were taken from first sample day milking post-
parturition (1 to 7 DIM) until each cow reached the last week before completing 60 DIM (52 to 
59 DIM). 
These measurements were digitized on a weekly basis this information was later utilized 
to generate possible covariables for the statistical models. 
Data editing 
Nedap made weekly behavior data available on the cloud content platform Box (Box, 
Inc., Redwood City, CA). The data was provided in Microsoft Excel format (Microsoft 
Corporation, Redmond, WA). At the end of the study, all data were merged into single files. 
Data from each tag were downloaded and imported into Microsoft Excel. The 15-minute data 
were summed into weekly totals from calving until 60 DIM (approximately 8 weeks). Weekly 
summations of number of steps, time spent lying down and walking (min) was then utilized to 
determine weekly means. Weekly summations and means were imported into SAS (Cary NC, 
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USA) for further analysis. Due to altered activity around calving time, pre-calving data from 
each study cow was excluded from the analysis to avoid bias. Additionally, since in this study 
cows were only studied up to their 60 DIM, any data collected after that point was also excluded.  
A total of 270 animals were enrolled in the study, but data from only 61 cows were 
utilized in the final analysis. Unfortunately, the amount of tags acquired was not enough to 
employ tags on all enrolled cows for the duration of the study, so tags needed to be removed 
from study cows they reached 60 DIM. Researchers and farm staff kept detailed records of when 
tags were moved to a new cow and updated the Velos system accordingly. However, the tags did 
not always update to associate the data to the new cow even though they were updated on the 
authors’ end. The integration from DairyComp and the processing unit might have caused issues, 
and the synch from DairyComp and Velos did not work properly; therefore, the connection 
between animal and tag did not present in the processing unit, and any data from tag was lost, 
since there was no animal to connect to. This system failure was not recognized until the data 
was analyzed because the tags were still functioning according to the Velos system, which was 
checked each day to ensure that no tags had failed. As a result of the missing data, out of a total 
of 32 weeks (whole duration of the study), only data from the first 12 weeks of the study were 
analyzed.  
Statistical Analyses 
The MIXED procedure of SAS was utilized to analyze leg activity, walking time, and 
lying time. The LSMEANS statement was used to determine: 1) average time spent walking 
(min/wk); 2) average time spent lying down (min/wk); and 3) amount of steps given (average 
amount of steps/wk). All mixed models included fixed effects of treatments and block, and 
random effect of cow within block. Other variables of interest, like BCS, LOC, and HYG, 
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disease incidence, and milk yield and components, were tested in each model as possible 
covariables; however, only variables with P < 0.10 were utilized on final models. Two-way 
interactions were tested in each model; however, only significant interactions (P ≤ 0.10) were 
kept in the model. 
The PHREG procedure was utilized to perform the Cox proportional hazards regression 
to determine the relative likelihood of cows displaying estrus within their first 60 DIM. In this 
analysis, effect of treatment, block, and month of calving were used as fixed effects. 
Additionally, the LIFESTEST procedure was used to assess treatment effects of treatment on 
estrus detection. The censoring variable was set to 1 to describe animals that showed the event 
under investigation (estrus). The log-rank and Wilcoxon test was used to determine treatment 
effect. 
Results and discussion 
Time to first detected heat 
Due to the mode of action of IMR, the increased number and activity of PMN could lead 
to more animals exhibiting clinically apparent inflammation and displaying more abnormal 
discharge (thick, white, purulent, and fetid odor), consequently increasing metritis detection 
(Oliveira, 2018).  In the present study, IMR cows had greater incidence of metritis (25% 
increase, P < 0.01), and were 2.21 more likely to develop the disease (P < 0.01, with a 95% 
confidence interval ranging from 1.31 to 3.76, results displayed in first part one of this report). 
Nevertheless, it is possible that despite the increased incidence of metritis, the uterine function 
could return to cyclicity without delaying the time to first detected heat.  
Imrestor treatment did not alter (P = 0.88) the hazard ratio of estrus occurrence during the 
first 60 DIM (hazard ratio = 0.99, 95% CI = 0.84 to 1.7; Table 1 and Figure 1) of cows. The 
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median calving-to-first detected heat interval for IMR and CTR cows was 47 and 46 d, 
respectively (P = 0.45). Interaction between block and treatment was not added to the final 
model due to lack of significance (P > 0.10). This findings are in agreement with  Zincola et al. 
(2018), who found that Imrestor treatment did not alter (P = 0.66) the hazard of cows being 
inseminated within the first 120 DIM (hazard ratio = 1.03, 95% CI = 0.89 to 1.19). 
Due to the reduced amount of animals that contributed to these results, more studies, with 
larger sample size, would be ideal to evaluate whether IMR treatment has the potential to affect 
day to first heat in dairy cows. 
Lying behavior 
Imrestor treatment did not affect time spend lying (P = 0.59, Table 1). On average, IMR 
cows and CON cows spent 87.3 and 88.4 hours/wk lying down (12.5 and 12.6 hours/d, 
respectively). The time spent lying down for both treatment groups is consistent with previous 
research that have found that dairy cows kept in free-stall barns should spend, in average, 11 to 
14 hours lying down (Haley et al., 2000). 
The effect of block was highly significant in this model (P < 0.01), and multiparous cows spent 
more lying down then primiparous. No interaction between treatments and block were observed 
(P > 0.05), therefore the effect of that interaction was not accounted in this model. Additionally, 
within all variables tested in this model, only lameness score met the criteria to be added to final 
model (P = 0.08). 
Lying is considered to be higher priority than eating when opportunities to perform these 
behaviors are restricted (Munksgaard et al., 2005). Adequate lying and resting time is positively 
associated with productivity, health, and welfare of dairy cattle (Cooper et al., 2008); on the 
other hand, decreased lying has been associated with pain, and with risk of becoming ill (Weary 
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et al., 2009). Therefore, the results found in the present study suggest the IMR treatment is not 
associated with negative consequences in the lying behavior and welfare or dairy cows. To the 
best of the authors’ knowledge, no other study has evaluated the differences in lying behavior 
between IMR and CON cows. 
Leg activity 
Imrestor did not significantly change the amount of steps given by cows; neither the time 
spent walking (P = 0.48 and 0.59, respectively). These results indicate that the increase in 
neutrophil numbers and neutrophil activity, typically observed in IMR treated cows, may not be 
associated with changes in activity of dairy cows in their first 60 DIM.  
If IMR treatment were to negatively change the natural behavior of cows (e.g. to reduce 
their lying time), production parameters could also be affected as a consequence. Additionally, a 
potential negative public perception of the product could arise, ultimately leading to a negative 
image of the treatment. Fortunately, that was not the case with IMR treatment. 
The effect of block was highly significant in these two models (P < 0.01), and 
primiparous cows spent more time walking, and consequently, also gave more steps on average 
week basis. These results are in agreement with previous research that have observed that 
primiparous cows spent more time feeding, visited the feed bunk more frequently, lay down 
more frequently, although spend less time lying when older multiparous cows (Naeve et. al., 
2017). No interaction between treatments and block were observed (P > 0.05), therefore effects 
of interactions were not accounted in any model.  
Diseased animals often exhibit abnormal or reduced activity (Proudfoot et al., 2009); 
therefore, changes in the walking behavior and number steps given are potential indicators and 
predictors of health issues such as postpartum disorders (metritis and retained placenta; 
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Sepúlveda-Varas et al., 2014). However, although IMR treated cows displayed increased metritis 
incidence, no differences in behavior were detected in this study.  
Although IMR cows displayed increased occurrence of metritis in their first 30 DIM, no 
differences were observed in time to first detected heat; suggesting that increased metritis 
occurrence was not associated with decreased reproductive status. Additionally, despite the 
increase in metritis occurrence, no difference in lying behavior was detected. In conclusion, the 
utilization of novel products in farm animals has the capability of affecting consumer concerns 
due to the possible change on health and well-being of farm animals, especially if their natural 
behavior is changed. However, the results found here indicate that IMR treatment, either via the 
expected physiological change in the immune system or other potential pathways following IMR 















Table 3.1 Point estimate, standard error, P-value, and hazard ratio associated with heat 







Treatment      
Control Ref. - - - 
Pegbovigrastim -0.13 0.009 0.15 0.88 
Parity     
Primiparous Ref. - - - 
Multiparous 0.12 0.009 < 0.01 1.13 














Table 3.2 Walking time, lying time, and leg activity (means ± SEM) of different age cows 





























0.02 0.48 < 0.01 











Figure 3.1 Effect of Imrestor on time to first detected heat in the first nine weeks of lactation 









Figure 3.2 Effect of Imrestor on leg activity and walking time (mean ± SE) in the first 8 
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